Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Does not yet change enterovirus management; leaves open targeted antiviral development pending experimental validation.
Enteroviruses are a large group of small nonenveloped viruses that cause common and debilitating illnesses affecting humans and animals worldwide. The capsid composed by viral structural proteins packs the RNA genome. It is becoming apparent that structural proteins of enteroviruses play versatile roles in the virus-host interaction in the viral life cycle, more than just a shell. Furthermore, structural proteins to some extent may be associated with viral virulence and pathogenesis. Better understanding the roles of structural proteins in enterovirus infection may lead to the development of potential antiviral strategies. Here, we discuss recent advances from studies on the role of structural proteins in enterovirus infection and antiviral therapeutics targeted structural proteins.
No takes yet. Share an insight, caveat, or question.
Wen et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: